Abstract
IMPORTANCE: Enterohemorrhagic Escherichia coli (EHEC) remains an important cause of diarrheal disease and complications worldwide, especially in children, yet there are no available vaccines for human use. Inadequate pre-clinical evaluation due to inconsistent animal models remains a major barrier to novel vaccine development. We demonstrate the usefulness of Stx2d-producing Citrobacter rodentium in assessing vaccine effectiveness because it more closely recapitulates human disease caused by EHEC.
Original language | English (US) |
---|---|
Pages (from-to) | e0226123 |
Journal | Microbiology Spectrum |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jan 11 2024 |
Keywords
- Citrobacter rodentium
- EHEC
- hemolytic uremic syndrome
- nanovaccines
- Shiga toxin
ASJC Scopus subject areas
- Physiology
- Ecology
- General Immunology and Microbiology
- Genetics
- Microbiology (medical)
- Cell Biology
- Infectious Diseases